{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T16:46:26Z","timestamp":1793810786458,"version":"4.6.1"},"reference-count":48,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:00:00Z","timestamp":1784332800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Victor Babe\u0219 University of Medicine and Pharmacy Timi\u0219oara"},{"id":[{"id":"https:\/\/ror.org\/00afdp487","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Medication-related osteonecrosis of the jaw (MRONJ) is a severe complication associated with antiresorptive therapy. Although several local and systemic risk factors have been documented, the role of metabolic biomarkers and their relationship with clinical characteristics remains insufficiently investigated. The aim of the present study was to evaluate the relationships between antiresorptive therapy, serum vitamin D levels, demographic characteristics, and lesion location in patients diagnosed with MRONJ. Materials and Methods: This retrospective study included 72 patients diagnosed with MRONJ, divided into three groups according to the antiresorptive therapy administered: zoledronic acid (n = 30), denosumab (n = 22), and oral bisphosphonates (n = 20). Clinical and demographic data, including age, sex, smoking status, serum vitamin D levels, number of extracted teeth, lesion location (mandibular versus maxillary), and associated comorbidities, were obtained from medical records. Statistical analysis was performed using Welch\u2019s ANOVA, Welch\u2019s t-test, chi-square, Fisher\u2019s exact, and Pearson and Spearman correlation analyses. Results: No significant differences in serum vitamin D levels were observed among the three antiresorptive therapy groups. However, patients with mandibular MRONJ had significantly lower serum vitamin D levels than those with maxillary involvement (p = 0.046). Lower serum vitamin D levels were independently associated with mandibular MRONJ after multivariable adjustment. Female sex and thyroid disease were more frequent in the oral bisphosphonate group. Additionally, patient age was moderately positively correlated with the number of extracted teeth (r = 0.440, p &lt; 0.001). Conclusions: This retrospective study identified a possible association between lower serum vitamin D levels and mandibular MRONJ. Given the observational design of the study, these findings should be interpreted with caution and require confirmation in larger prospective studies.<\/jats:p>","DOI":"10.3390\/medicina62071394","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:47:32Z","timestamp":1784508452000},"page":"1394","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical Characteristics and Serum Vitamin D Levels in Patients with MRONJ Associated with Antiresorptive Therapy: A Retrospective Study"],"prefix":"10.3390","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3891-2082","authenticated-orcid":false,"given":"Ivona Mihaela","family":"Hum","sequence":"first","affiliation":[{"name":"Doctoral School, \u201cVictor Babe\u0219\u201d University of Medicine and Pharmacy, 300041 Timisoara, Romania"},{"name":"Department of Balneology, Medical Recovery and Rheumatology, Family Medicine University Clinic, Center for Preventive Medicine, Center for Advanced Research in Cardiovascular Pathology and Hemostaseology, \u201cVictor Babe\u0219\u201d University of Medicine and Pharmacy, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9437-221X","authenticated-orcid":false,"given":"Laura","family":"Atyim","sequence":"additional","affiliation":[{"name":"Doctoral School, \u201cVictor Babe\u0219\u201d University of Medicine and Pharmacy, 300041 Timisoara, Romania"},{"name":"Department of Balneology, Medical Recovery and Rheumatology, Family Medicine University Clinic, Center for Preventive Medicine, Center for Advanced Research in Cardiovascular Pathology and Hemostaseology, \u201cVictor Babe\u0219\u201d University of Medicine and Pharmacy, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8529-230X","authenticated-orcid":false,"given":"Raluca","family":"Maracineanu","sequence":"additional","affiliation":[{"name":"Doctoral School, \u201cVictor Babe\u0219\u201d University of Medicine and Pharmacy, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Folescu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cVictor Babes\u201d University of Medicine and Pharmacy, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1784-9209","authenticated-orcid":false,"given":"Loredana Gabriela","family":"Stana","sequence":"additional","affiliation":[{"name":"Department I, Discipline of Anatomy and Embryology, \u201cVictor Babes\u201d University of Medicine and Pharmacy, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0622-5126","authenticated-orcid":false,"given":"Roxana","family":"Folescu","sequence":"additional","affiliation":[{"name":"Department of Balneology, Medical Recovery and Rheumatology, Family Medicine University Clinic, Center for Preventive Medicine, Center for Advanced Research in Cardiovascular Pathology and Hemostaseology, \u201cVictor Babe\u0219\u201d University of Medicine and Pharmacy, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1200\/JCO.19.01186","article-title":"Medication-Related Osteonecrosis of the Jaw: MASCC\/ISOO\/ASCO Clinical Practice Guideline","volume":"37","author":"Yarom","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.oooo.2021.03.006","article-title":"Quality of life in patients affected by medication-related osteonecrosis of the jaws: A systematic review","volume":"132","author":"Bensi","year":"2021","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American Association of Oral and Maxillofacial Surgeons\u2019 Position Paper on Medication-Related Osteonecrosis of the Jaws\u20142022 Update","volume":"80","author":"Ruggiero","year":"2022","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4103\/njms.NJMS_236_20","article-title":"Medication-related osteonecrosis of the jaw: An update","volume":"13","author":"Bansal","year":"2022","journal-title":"Natl. J. Maxillofac. Surg."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e10785","DOI":"10.1002\/jbm4.10785","article-title":"Pathophysiology of Medication-Related Osteonecrosis of the Jaw\u2014A Minireview","volume":"7","author":"Tetradis","year":"2023","journal-title":"JBMR Plus"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41368-020-00093-2","article-title":"Pathogenesis and multidisciplinary management of medication-related osteonecrosis of the jaw","volume":"12","author":"He","year":"2020","journal-title":"Int. J. Oral Sci."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"De Cicco, D., Boschetti, C.E., Santagata, M., Colella, G., Staglian\u00f2, S., Gaggl, A., Bottini, G.B., Vitagliano, R., and D\u2019amato, S. (2023). Medication-Related Osteonecrosis of the Jaws: A Comparison of SICMF\u2013SIPMO and AAOMS Guidelines. Diagnostics, 13.","DOI":"10.3390\/diagnostics13132137"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Lorenzo-Pouso, A.I., Bag\u00e1n, J., Bag\u00e1n, L., G\u00e1ndara-Vila, P., Chamorro-Petronacci, C.M., Castelo-Baz, P., Blanco-Carri\u00f3n, A., Blanco-Fern\u00e1ndez, M.\u00c1., \u00c1lvarez-Calder\u00f3n, \u00d3., and Carballo, J. (2021). Medication-Related Osteonecrosis of the Jaw: A Critical Narrative Review. J. Clin. Med., 10.","DOI":"10.3390\/jcm10194367"},{"key":"ref_10","first-page":"e326","article-title":"Medication-related osteonecrosis of the jaws (MRONJ) in cancer patients treated with denosumab vs. zoledronic acid: A systematic review and meta-analysis","volume":"25","author":"Limones","year":"2020","journal-title":"Med. Oral Patol. Oral Cir. Bucal"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.jds.2025.02.002","article-title":"Risk assessment and drug interruption guidelines for dentoalveolar surgery in patients with osteoporosis receiving anti-resorptive therapy","volume":"20","author":"Wei","year":"2025","journal-title":"J. Dent. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-Rivero, M., and Medina, M.\u00c1. (2025). Vitamin D as a Systemic Regulatory Axis: From Homeostasis to Multiorgan Disease. Biomedicines, 13.","DOI":"10.3390\/biomedicines13112733"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Dalle Carbonare, L., Mottes, M., and Valenti, M.T. (2021). Medication-Related Osteonecrosis of the Jaw (MRONJ): Are Antiresorptive Drugs the Main Culprits or Only Accomplices? The Triggering Role of Vitamin D Deficiency. Nutrients, 13.","DOI":"10.3390\/nu13020561"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e318","DOI":"10.5327\/2525-5711.318","article-title":"Vitamin D3 deficiency and MRONJ: Insights from a Bi-Center Study in Argentina. A preliminary cross-sectional study","volume":"10","author":"Gilligan","year":"2025","journal-title":"J. Oral Diagn."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Maracineanu, R., Talpos-Niculescu, S., Dinu\u021bi, M., Pricop, M., Folescu, R., Semenescu, A.-D., and Hum, I.M. (2026). Preoperative Vitamin D as Predictor of MRONJ: A Retrospective Multivariate Analysis. J. Clin. Med., 15.","DOI":"10.3390\/jcm15051712"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Campisi, G., Mauceri, R., Bertoldo, F., Bettini, G., Biasotto, M., Colella, G., Consolo, U., Di Fede, O., Favia, G., and Fusco, V. (2020). Medication-Related Osteonecrosis of Jaws (MRONJ) Prevention and Diagnosis: Italian Consensus Update 2020. Int. J. Environ. Res. Public Health, 17.","DOI":"10.3390\/ijerph17165998"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jcms.2010.05.009","article-title":"Osteoporosis and bisphosphonates-related osteonecrosis of the jaw: Not just a sporadic coincidence\u2014A multi-centre study","volume":"39","author":"Otto","year":"2011","journal-title":"J. Craniomaxillofac. Surg."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s00198-023-06818-3","article-title":"Risk comparison of osteonecrosis of the jaw in osteoporotic patients treated with bisphosphonates vs. denosumab: A multi-institutional retrospective cohort study in Taiwan","volume":"34","author":"Liu","year":"2023","journal-title":"Osteoporos. Int."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.sdentj.2022.01.003","article-title":"Medication-Related Osteonecrosis of the Jaw (MRONJ): A Review of Pathophysiology, Risk Factors, Preventive Measures and Treatment Strategies","volume":"34","author":"AlRowis","year":"2022","journal-title":"Saudi Dent. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bone.2018.01.030","article-title":"Removal of matrix-bound zoledronate prevents post-extraction osteonecrosis of the jaw by rescuing osteoclast function","volume":"110","author":"Elsayed","year":"2018","journal-title":"Bone"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Delitala, A.P., Scuteri, A., and Doria, C. (2020). Thyroid Hormone Diseases and Osteoporosis. J. Clin. Med., 9.","DOI":"10.3390\/jcm9041034"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0140-6736(18)32112-3","article-title":"Osteoporosis","volume":"393","author":"Compston","year":"2019","journal-title":"Lancet"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"Diagnosis and management of osteonecrosis of the jaw: A systematic review and international consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41413-023-00306-4","article-title":"Insights and implications of sexual dimorphism in osteoporosis","volume":"12","author":"Zhang","year":"2024","journal-title":"Bone Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1210\/er.2015-1106","article-title":"Role of Thyroid Hormones in Skeletal Development and Bone Maintenance","volume":"37","author":"Bassett","year":"2016","journal-title":"Endocr. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Zhu, S., Pang, Y., Xu, J., Chen, X., Zhang, C., Wu, B., and Gao, J. (2022). Endocrine Regulation on Bone by Thyroid. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.873820"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Sosa-Henr\u00edquez, M., Torregrosa-Suau, \u00d3., G\u00f3mez de Tejada-Romero, M.J., Cancelo-Hidalgo, M.J., Tarazona-Santabalbina, F.J., Etxebarria-Foronda, I., D\u00edaz-Guerra, G.M., and Vald\u00e9s-Llorca, C. (2025). Rethinking Vitamin D Deficiency: Controversies and Practical Guidance for Clinical Management. Nutrients, 17.","DOI":"10.3390\/nu17223573"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"279","DOI":"10.11005\/jbm.2021.28.4.279","article-title":"Medication Related Osteonecrosis of the Jaw: 2021 Position Statement of the Korean Society for Bone and Mineral Research and the Korean Association of Oral and Maxillofacial Surgeons","volume":"28","author":"Kim","year":"2021","journal-title":"J. Bone Metab."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/j.jcms.2017.09.015","article-title":"Vitamin D (25-OHD) deficiency may increase the prevalence of medication-related osteonecrosis of the jaw","volume":"45","author":"Heim","year":"2017","journal-title":"J. Craniomaxillofac Surg."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Michalak, F., Dominiak, M., Kiryk, J., Popecki, P., Kubicki, D., Matys, J., and Grzech-Le\u015bniak, K. (2025). The Influence of Vitamin D Levels and Supplementation on the Treatment of Patients Affected by MRONJ. Appl. Sci., 15.","DOI":"10.3390\/app15020670"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1200\/JCO.2008.20.8629","article-title":"Vitamin D in cancer patients: Above all, do no harm","volume":"27","author":"Goodwin","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc3691","article-title":"The role of vitamin D in reducing cancer risk and progression","volume":"14","author":"Feldman","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"De Martinis, M., Allegra, A., Sirufo, M.M., Tonacci, A., Pioggia, G., Raggiunti, M., Ginaldi, L., and Gangemi, S. (2021). Vitamin D Deficiency, Osteoporosis and Effect on Autoimmune Diseases and Hematopoiesis: A Review. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22168855"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Zhang, W., Gao, L., Ren, W., Li, S., Zheng, J., Li, S., Jiang, C., Yang, S., and Zhi, K. (2021). The Role of the Immune Response in the Development of Medication-Related Osteonecrosis of the Jaw. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.606043"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Lon\u010dar Brzak, B., Horvat Aleksijevi\u0107, L., Vindi\u0161, E., Kordi\u0107, I., Grani\u0107, M., Vidovi\u0107 Juras, D., and Andabak Rogulj, A. (2023). Osteonecrosis of the Jaw. Dent. J., 11.","DOI":"10.3390\/dj11010023"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.bjoms.2020.12.014","article-title":"Evaluation of segmental mandibular resection without microvascular reconstruction in patients affected by medication-related osteonecrosis of the jaw: A systematic review","volume":"59","author":"Sacco","year":"2021","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/odi.12992","article-title":"Surgical treatment of medication-related osteonecrosis of the upper jaw: Case series","volume":"25","author":"Aljohani","year":"2019","journal-title":"Oral Dis."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"D\u2019Agostino, S., Valentini, G., Dolci, M., and Ferrara, E. (2023). Potential Relationship between Poor Oral Hygiene and MRONJ: An Observational Retrospective Study. Int. J. Environ. Res. Public Health, 20.","DOI":"10.3390\/ijerph20075402"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40729-021-00323-0","article-title":"Clinical considerations for medication-related osteonecrosis of the jaw: A comprehensive literature review","volume":"7","author":"Kawahara","year":"2021","journal-title":"Int. J. Implant. Dent."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/annonc\/mdr435","article-title":"Incidence, risk factors, and outcomes of osteonecrosis of the jaw: Integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases","volume":"23","author":"Saad","year":"2012","journal-title":"Ann. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.joms.2020.12.045","article-title":"Factors Influencing Severity of Medication-Related Osteonecrosis of the Jaw: A Retrospective Study","volume":"79","author":"Feng","year":"2021","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_42","first-page":"e6944","article-title":"Medication-related Osteonecrosis of the Jaw: A Review","volume":"12","author":"AlDhalaan","year":"2020","journal-title":"Cureus"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Ciobanu, G.A., Camen, A., Ionescu, M., Vlad, D., Munteanu, C.M., Gheorghi\u021b\u0103, M.I., Lungulescu, C.V., Staicu, I.E., Sin, E.C., and Chivu, L. (2023). Risk Factors for Medication-Related Osteonecrosis of the Jaw\u2014A Binomial Analysis of Data of Cancer Patients from Craiova and Constanta Treated with Zoledronic Acid. J. Clin. Med., 12.","DOI":"10.3390\/jcm12113747"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1111\/odi.14449","article-title":"Medication-related osteonecrosis of the jaw triggered by endodontic failure in oncologic patients","volume":"29","author":"Tempesta","year":"2023","journal-title":"Oral Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1111\/jgs.18414","article-title":"Medication-related osteonecrosis of the jaw: A disease of significant importance for older patients","volume":"71","author":"Boston","year":"2023","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Migliorati, C.A. (2022). Oral Complications in Cancer Patients-Medication-Related Osteonecrosis of the Jaw (MRONJ). Front. Oral Health, 3.","DOI":"10.3389\/froh.2022.866871"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.joms.2021.12.007","article-title":"Prevalence, Incidence Rate, and Risk Factors of Medication-Related Osteonecrosis of the Jaw in Patients with Osteoporosis and Cancer: A Nationwide Population-Based Study in Japan","volume":"80","author":"Ishimaru","year":"2022","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/odi.13046","article-title":"Systemic comorbidities are associated with medication-related osteonecrosis of the jaws: Case-control study","volume":"25","author":"McGowan","year":"2019","journal-title":"Oral Dis."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/7\/1394\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T01:20:24Z","timestamp":1784510424000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/7\/1394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,18]]},"references-count":48,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["medicina62071394"],"URL":"https:\/\/doi.org\/10.3390\/medicina62071394","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,18]]}}}